Synopsis
Synopsis
0
VMF
0
Europe
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-
2. Dihydrate, Ondansetron Monohydrochloride
3. Gr 38032f
4. Gr-38032f
5. Gr38032f
6. Hydrochloride, Ondansetron
7. Monohydrochloride Dihydrate, Ondansetron
8. Monohydrochloride, Ondansetron
9. Odt, Zofran
10. Ondansetron
11. Ondansetron Monohydrochloride
12. Ondansetron Monohydrochloride Dihydrate
13. Ondansetron, (+,-)-isomer
14. Ondansetron, (r)-isomer
15. Ondansetron, (s)-isomer
16. Sn 307
17. Sn-307
18. Sn307
19. Zofran
20. Zofran Odt
1. Ondansetron Hcl
2. 99614-01-4
3. Zofran
4. Ondemet
5. Emeset
6. Ondansetron (hydrochloride)
7. Zofran Odt
8. Nsc 665799
9. Ondansetronhydrochloride
10. 2999f27mad
11. Nsc-665799
12. C18h20cln3o
13. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Monohydrochloride
14. Emetron
15. 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one Hydrochloride
16. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4h-carbazol-4-one Hydrochloride
17. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-2,3-dihydro-1h-carbazol-4(9h)-one Hydrochloride
18. Smr000469179
19. Gr 38032
20. Unii-2999f27mad
21. Sr-01000763250
22. Zofran Preservative Free
23. Zofran And Dextrose In Plastic Container
24. Cpd000469179
25. Ondansetron Hydrochloride Preservative Free
26. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one Monohydrochloride
27. Schembl41455
28. Mls001304076
29. Mls001401397
30. Mls002222312
31. Regid_for_cid_68647
32. Gr 38032 Hcl
33. Ondansetron Hydrochloride, 98%
34. Chembl1201111
35. Ondansetron Hydrochloride- Bio-x
36. Ondansetron Hydrochloride And Dextrose In Plastic Container
37. Dtxsid701027913
38. Hms1571c18
39. Ondansetron Hydrochloride (zofran)
40. Hy-b0002
41. Ondansetron Hydrochloride And Sodium Chloride In Plastic Container
42. Mfcd00764297
43. Nsc665799
44. S1390
45. Ondansetron Hydrochloride [mi]
46. Akos015889292
47. Ab07046
48. Ccg-100852
49. Ccg-221058
50. Cs-1715
51. Gs-3597
52. H39o049
53. Nc00102
54. Ac-12464
55. Bo164177
56. Ondansetron Hydrochloride [who-dd]
57. Ondansetron Hydrochloride Anhydrous
58. O0407
59. Sw100810-5
60. Vu0424014-2
61. C90628
62. (+/-)-ondansetron Hydrochloride Anhydrous
63. A800774
64. Ondansetron Hydrochloride Anhydrous, (+/-)-
65. Q-201515
66. Sr-01000763250-5
67. Q27254405
68. 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one;hydrochloride
69. 1,2,3,4-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-9h-carbazol-4-one Hydrochloride
70. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Hydrochloride (1:1)
71. 9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1h-carbazol-4-one Hydrochloride
Molecular Weight | 329.8 g/mol |
---|---|
Molecular Formula | C18H20ClN3O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 329.1294900 g/mol |
Monoisotopic Mass | 329.1294900 g/mol |
Topological Polar Surface Area | 39.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 440 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride |
Drug Label | The active ingredient in ZOFRAN Tablets and ZOFRAN Oral Solution is ondansetron hydrochloride (HCl) as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (1, 2, 3, 9-te... |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Tablet; Injectable; Solution |
Route | oral; Injection; Oral |
Strength | eq 4mg base; eq 2mg base/ml; eq 4mg base/5ml; eq 16mg; eq 16mg base; 16mg; eq 24mg base; eq 8mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Silarx; Bedford; Hospira; Gland Pharma; Sun Pharm Inds (in); Teva; Apotex; Hikma Farmaceutica; Aurobindo Pharma; Natco Pharma; Taro; Sandoz; Par Pharm; Roxane; Glenmark Generics; Emcure Pharms; Fresenius Kabi Usa; Ipca Labs; Hikm |
2 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Hospira; Teva; Hikma Farmaceutica; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Hikma Maple; Claris Lifesciences; Taro Pharms Ireland; Luitpold; Bedford Labs; Agila Speclts; Bd Rx |
3 of 6 | |
---|---|
Drug Name | Zofran preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Glaxosmithkline |
4 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride |
Drug Label | The active ingredient in ZOFRAN Tablets and ZOFRAN Oral Solution is ondansetron hydrochloride (HCl) as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (1, 2, 3, 9-te... |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Tablet; Injectable; Solution |
Route | oral; Injection; Oral |
Strength | eq 4mg base; eq 2mg base/ml; eq 4mg base/5ml; eq 16mg; eq 16mg base; 16mg; eq 24mg base; eq 8mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Silarx; Bedford; Hospira; Gland Pharma; Sun Pharm Inds (in); Teva; Apotex; Hikma Farmaceutica; Aurobindo Pharma; Natco Pharma; Taro; Sandoz; Par Pharm; Roxane; Glenmark Generics; Emcure Pharms; Fresenius Kabi Usa; Ipca Labs; Hikm |
5 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Hospira; Teva; Hikma Farmaceutica; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Hikma Maple; Claris Lifesciences; Taro Pharms Ireland; Luitpold; Bedford Labs; Agila Speclts; Bd Rx |
6 of 6 | |
---|---|
Drug Name | Zofran preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Glaxosmithkline |
Treatment of alcohol use disorder
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16317
Submission : 2002-12-13
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-23
Pay. Date : 2015-09-09
DMF Number : 15436
Submission : 2001-05-15
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17053
Submission : 2003-12-22
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15642
Submission : 2001-10-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16786
Submission : 2003-09-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-23
Pay. Date : 2018-09-13
DMF Number : 15752
Submission : 2001-12-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15783
Submission : 2001-12-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15724
Submission : 2001-11-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-17
Pay. Date : 2021-08-12
DMF Number : 16710
Submission : 2003-07-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-25
Pay. Date : 2020-02-20
DMF Number : 15990
Submission : 2002-05-27
Status : Active
Type : II
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2005-056 - Rev 00
Status : Valid
Issue Date : 2012-05-24
Type : Chemical
Substance Number : 2016
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2005-071 - Rev 06
Status : Valid
Issue Date : 2023-05-23
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2004-209 - Rev 03
Status : Valid
Issue Date : 2020-03-04
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2003-130 - Rev 01
Status : Valid
Issue Date : 2011-12-12
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2003-053 - Rev 01
Status : Valid
Issue Date : 2011-08-22
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R0-CEP 2017-185 - Rev 00
Status : Expired
Issue Date : 2018-08-17
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2007-237 - Rev 02
Status : Valid
Issue Date : 2019-09-18
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2009-319 - Rev 04
Status : Valid
Issue Date : 2019-09-16
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R0-CEP 2019-252 - Rev 00
Status : Valid
Issue Date : 2021-12-06
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R0-CEP 2009-191 - Rev 02
Status : Expired
Issue Date : 2014-03-31
Type : Chemical
Substance Number : 2016
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron hydrochloride hydrate
Registration Number : 302MF10019
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2020-01-31
Latest Date of Registration : 2020-01-31
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron hydrochloride hydrate
Registration Number : 221MF10130
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2009-06-30
Latest Date of Registration : 2016-02-18
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Registration Number : 307MF10012
Registrant's Address : 13 Pallagi u(´)t, Debrecen, 4042-Hungary
Initial Date of Registration : 2025-01-09
Latest Date of Registration : 2025-01-09
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Ondansetron hydrochloride (Teva)
Registration Number : 219MF10022
Registrant's Address : 13 Pallagi u(´)t, Debrecen, 4042-Hungary
Initial Date of Registration : 2007-01-22
Latest Date of Registration : 2017-05-16
Ondansetron hydrochloride hydrate (for manufacturing purposes only)
Registration Number : 306MF10103
Registrant's Address : Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, Gujarat, INDIA
Initial Date of Registration : 2024-07-17
Latest Date of Registration : 2024-07-17
Registration Number : 219MF10374
Registrant's Address : 1205 11th Street, Charles City, Iowa, U.S. S. A.
Initial Date of Registration : 2007-12-19
Latest Date of Registration : 2007-12-19
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron Hydrochloride Dihyrate Ph.Eur
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
Ondansetron Hydrochloride EP/USP
Date of Issue : 2022-04-04
Valid Till : 2025-01-13
Written Confirmation Number : WC-0331A2
Address of the Firm : Plot No. 38, Rafaleshwar, GIDC, N. H. No 8/A, At & post Jambudia ? 363 642 Tal: ...
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm : Plot No. 24/2, & 25, Phase -IV, GIDC Industrial Zone, At & Post - Panoli, Dist.-...
Ondansetron Hydrochloride USP/EP
Date of Issue : 2022-10-17
Valid Till : 2025-08-08
Written Confirmation Number : WC-0382
Address of the Firm : Survey No 353, Domadugu (V), Gummadidala (M), Sangareddy District, Telangana (St...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron hydrochloride hydrate
Registrant Name : Sangjin Corporation
Registration Date : 2021-06-22
Registration Number : 20210426-47-B-440-20(1)
Manufacturer Name : Dr. Reddy's Laboratories Ltd...
Manufacturer Address : Peddadevulapally Village, Tripuraram Mandal, Nalgonda District - 508 207, Telangana S...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron hydrochloride hydrate
Registrant Name : Samil Pharmaceutical Co., Ltd.
Registration Date : 2021-04-26
Registration Number : 20210426-47-B-440-20
Manufacturer Name : Dr. Reddy's Laboratories Ltd...
Manufacturer Address : Chemical Technical Operations - Unit V Peddadevulapally Village, Tripuraram Mandal, N...
Ondansetron hydrochloride hydrate
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2013-03-13
Registration Number : 20130313-47-B-343-17
Manufacturer Name : Cambrex Charles City, Inc
Manufacturer Address : 1205 11th st. Charles City, IA 50616, USA
Ondansetron hydrochloride hydrate
Registrant Name : Korea United Pharmaceutical Co., Ltd.
Registration Date : 2013-12-27
Registration Number : 20100226-47-B-298-13(1)
Manufacturer Name : IPCA Laboratories Limited
Manufacturer Address : PO Sejavta, District-Ratlam (MP) 457001, India
Registrant Name : Sampoong Pharmachem Co., Ltd.
Registration Date : 2025-06-24
Registration Number : 20250624-47-B-491-22
Manufacturer Name : Qilu Pharmaceutical Co., Ltd
Manufacturer Address : Circular Economy Demonstration Park, Laoling County, Dezhou City, Shandong Province, ...
Ondansetron hydrochloride hydrate
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2020-05-22
Registration Number : 20120925-47-B-347-16(3)
Manufacturer Name : Qilu Pharmaceutical Co., Ltd...
Manufacturer Address : No. 23999 Gong Ye Bei Road, Jinan, Shandong Province, 250100, PR China
Ondansetron hydrochloride hydrate
Registrant Name : Sampoong Pharmachem Co., Ltd.
Registration Date : 2012-09-25
Registration Number : 20120925-47-B-347-16
Manufacturer Name : Qilu Pharmaceutical Co., Ltd...
Manufacturer Address : No. 23999 Gong Ye Bei Road, Jinan, Shandong Province, 250100, PR China
Ondansetron hydrochloride hydrate
Registrant Name : Hansol Pharma Co., Ltd.
Registration Date : 2020-03-04
Registration Number : 20120925-47-B-347-16(2)
Manufacturer Name : Qilu Pharmaceutical Co., Ltd...
Manufacturer Address : No. 23999 Gong Ye Bei Road, Jinan, Shandong Province, 250100, PR China
Registrant Name : Seongun Pharmacopia Co., Ltd.
Registration Date : 2024-07-19
Registration Number : 20120925-47-B-347-16(4)
Manufacturer Name : Qilu Pharmaceutical Co., Ltd...
Manufacturer Address : No.243 Gong Ye Bei Road, Jinan, PRChina
Ondansetron hydrochloride hydrate
Registrant Name : Myungmoon Pharmaceutical Co., Ltd.
Registration Date : 2019-06-11
Registration Number : 20050831-47-B-122-04(1)
Manufacturer Name : Laxai Life Sciences Private ...
Manufacturer Address : Plot No. 9/A, Phase-III, Jeedimetla, Quthbullapur, Medchal-Malkajgiri, District-50005...
NDC Package Code : 64567-0005
Start Marketing Date : 2009-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-017
Start Marketing Date : 2010-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-377
Start Marketing Date : 2023-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1853
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1850
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1852
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2415
Start Marketing Date : 2007-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 63850-2706
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-4320
Start Marketing Date : 2008-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65129-2161
Start Marketing Date : 2001-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : Emay Pharmaceuticals Pvt Ltd functions as the merchant export division of M/s. Bhavna Laboratories Pvt Ltd. As a GMP-approved API manufacturing company, we boast over three decades...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
About the Company : Zeal MediPharma is a globally recognized Star One Export House, serving customers in over 50 countries for more than two decades. We specialize in sourcing and exporting high-quali...
About the Company : Venkar Chemicals Pvt. Ltd. is a WHO-GMP, ISO 9001:2008, and ISO 14000:2004 certified company and a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediate...
About the Company : We are Rampex Labs, a fully cGMP compliant pharmaceutical intermediates plant located in the outskirts of Hyderabad, India. Our company was founded in 2004 with commercial operatio...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : France
Brand Name : Ondansetron HCl
Dosage Form : Oro-Dispersible Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Regulatory Info :
Registration Country : France
Brand Name : Ondansetron Hydrochloride
Dosage Form : Oro-Dispersible Tablet
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ACCEL-ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging : 10
Approval Date :
Application Number : 2478927
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Dosage Strength : 16MG
Packaging :
Approval Date :
Application Number : 77303
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Packaging :
Approval Date : 2013-07-19
Application Number : 202253
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ONDANSETRON INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number : 2503905
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Packaging :
Approval Date : 2014-09-08
Application Number : 203711
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 24MG BASE
Packaging :
Approval Date : 2011-03-28
Application Number : 77729
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 8MG BASE
Packaging :
Approval Date : 2007-06-25
Application Number : 76252
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Packaging :
Approval Date : 2006-12-26
Application Number : 77577
Regulatory Info : RX
Registration Country : USA
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2006-12-26
Application Number : 77368
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 8MG BASE
Approval Date : 2007-07-31
Application Number : 78539
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 4MG BASE
Approval Date : 2007-06-25
Application Number : 77303
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AP
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2012-06-15
Application Number : 90648
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AB
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 8MG BASE
Approval Date : 2007-06-25
Application Number : 77535
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AP
Brand Name : ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2006-12-26
Application Number : 77011
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AB
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 4MG BASE
Approval Date : 2014-01-23
Application Number : 203761
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 8MG BASE
Approval Date : 2007-06-25
Application Number : 76930
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD :
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Dosage Strength : EQ 16MG
Approval Date :
Application Number : 76930
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AP
Brand Name : ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2007-06-27
Application Number : 77551
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ACCEL-ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging : 10
Approval Date :
Application Number : 2478935
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : AURO-ONDANSETRON INJECTION
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number : 2491532
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE)
Brand Name : MAR-ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging : Oct-30
Approval Date :
Application Number : 2371758
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE)
Brand Name : MINT-ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging : Oct-30
Approval Date :
Application Number : 2305259
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : PMS-ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging : 10/100
Approval Date :
Application Number : 2258196
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number : 2274418
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging : 100
Approval Date :
Application Number : 2421402
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging : 100
Approval Date :
Application Number : 2421410
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ONDANSETRON
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2541424
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
Brand Name : ONDANSETRON INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging : 2ML/4ML
Approval Date :
Application Number : 2464578
Regulatory Info :
Registration Country : Canada
Regulatory Info : Generic
Registration Country : South Africa
Ondansetron (as hydrochloride)
Brand Name : Sabax Ondansetron injection 4mg/2ml
Dosage Form : INJ
Dosage Strength : 2mg/ml
Packaging : 10X2mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Ondansetron (as hydrochloride)
Brand Name : Sabax Ondansetron injection 8mg/4ml
Dosage Form : INJ
Dosage Strength : 2mg/ml
Packaging : 10X4mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zofer 4 Mg Injection
Dosage Form : INJ
Dosage Strength : 2mg /ml
Packaging : 2X5mg /ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zofer 8 Mg Injection
Dosage Form : INJ
Dosage Strength : 2mg /ml
Packaging : 4X5mg /ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zofer 4 Mg Tablets
Dosage Form : FCT
Dosage Strength : 4mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zofer 8 Mg Tablets
Dosage Form : FCT
Dosage Strength : 8mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zofer Rapitab 4
Dosage Form : DSP
Dosage Strength : 4mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zofer Rapitab 8
Dosage Form : DSP
Dosage Strength : 8mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info :
Registration Country : France
Brand Name : Ondansetron HCl
Dosage Form : Oro-Dispersible Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Oro-Dispersible Tablet
Dosage Strength : 4MG
Brand Name : Ondansetron HCl
Approval Date :
Application Number :
Registration Country : France
Regulatory Info :
Registration Country : France
Brand Name : Ondansetron Hydrochlor...
Dosage Form : Oro-Dispersible Tablet
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Oro-Dispersible Tablet
Dosage Strength : 8MG
Brand Name : Ondansetron Hydrochlor...
Approval Date :
Application Number :
Registration Country : France
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Film Coated Tablet
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Vomistop
Dosage Form : Syrup
Dosage Strength : 2MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Syrup
Dosage Strength : 2MG/5ML
Brand Name : Vomistop
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Vomigo
Dosage Form : INJECTION
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 20007
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 2MG
Brand Name : Vomigo
Approval Date :
Application Number : 20007
Registration Country : India
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Otron
Dosage Form : INJECTION
Dosage Strength : 5MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging :
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 5MG/2ML
Brand Name : Otron
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 4MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Ampoule
Dosage Strength : 4MG/2ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Injection / Infusion S...
Dosage Strength : 8MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Injection / Infusion S...
Dosage Strength : 8MG/4ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : ORALLY DISINTEGRATING ...
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : ORALLY DISINTEGRATING ...
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Dosage Form : Tablet
Grade : Not Available
Brand Name : Kollicoat Protect
Application : Coating Systems & Additives
Excipient Details : Flexible water soluble instant release coating polymer, especially used for moisture protection
Pharmacopoeia Ref : Excipient based on Kollicoat®...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer
Dosage Form : Granule / Pellet
Grade : Not Available
Brand Name : Kollicoat SR 30 D
Application : Taste Masking
Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.
Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Emulsion
Grade : Not Available
Application : Topical
Excipient Details : Self-emulsifying and consistency building, easy-to-use base for dermatological creams
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : Wetting agent, reduces disintegration time, Ionic solubilizer, high HLB anionic emulsifier for semi-solids and foams.
Pharmacopoeia Ref : Ph. Eur.: Sodium Laurilsulfate...
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Capsule
Grade : Not Available
Dosage Form : Emulsion
Grade : Not Available
Brand Name : Kollisolv PEG 300
Application : Solubilizers
Excipient Details : Liquid plasticizer, solvent for oral and topical applications, hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 300
Dosage Form : Orodispersible Tablet
Grade : Not Available
Application : Chewable & Orodispersible Aids
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Lactose
Dosage Form : Tablet
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Citric acid monohydrate occurs as colorless or translucent crystals, or as a white crystalline, effervescent powder.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Citric Acid Excipient
Dosage Form : Emulsion
Grade : Topical
Application : Rheology Modifiers
Excipient Details : Polyglykol 400 is a liquid PEG excipient grade product which is used as solvent, humectant, coating agent and viscosity enhancer.
Pharmacopoeia Ref : USP-NF: Polyethylene glycol 40...
Technical Specs : average molar mass 400 g/mol
Ingredient(s) : Polyethylene Glycol 400
Excipients by Applications
Global Sales Information
Market Place
Reply
25 Dec 2024
Reply
19 Dec 2024
Reply
14 Oct 2024
Reply
23 Sep 2024
Reply
29 Mar 2023
Reply
20 Oct 2022
Reply
25 Dec 2021
Reply
27 Jul 2021
Reply
03 Apr 2021
Reply
12 Jun 2020
Reply
08 May 2025
Reply
20 Dec 2021
REF. STANDARDS & IMPURITIES
USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.
CAS Number : 99614-14-9
Quantity Per Vial :
Price ($) : 950
Catalog Number : 1A08630
Current Lot :
Previous Lot :
NDC Code :
ABOUT THIS PAGE
43
PharmaCompass offers a list of Ondansetron Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ondansetron Hydrochloride manufacturer or Ondansetron Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ondansetron Hydrochloride manufacturer or Ondansetron Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ondansetron Hydrochloride API Price utilized in the formulation of products. Ondansetron Hydrochloride API Price is not always fixed or binding as the Ondansetron Hydrochloride Price is obtained through a variety of data sources. The Ondansetron Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ondansetron Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ondansetron Hydrochloride, including repackagers and relabelers. The FDA regulates Ondansetron Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ondansetron Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ondansetron Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ondansetron Hydrochloride supplier is an individual or a company that provides Ondansetron Hydrochloride active pharmaceutical ingredient (API) or Ondansetron Hydrochloride finished formulations upon request. The Ondansetron Hydrochloride suppliers may include Ondansetron Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ondansetron Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ondansetron Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ondansetron Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ondansetron Hydrochloride DMFs exist exist since differing nations have different regulations, such as Ondansetron Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ondansetron Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ondansetron Hydrochloride USDMF includes data on Ondansetron Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ondansetron Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ondansetron Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ondansetron Hydrochloride Drug Master File in Japan (Ondansetron Hydrochloride JDMF) empowers Ondansetron Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ondansetron Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Ondansetron Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ondansetron Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ondansetron Hydrochloride Drug Master File in Korea (Ondansetron Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ondansetron Hydrochloride. The MFDS reviews the Ondansetron Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Ondansetron Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ondansetron Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ondansetron Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ondansetron Hydrochloride suppliers with KDMF on PharmaCompass.
A Ondansetron Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Ondansetron Hydrochloride Certificate of Suitability (COS). The purpose of a Ondansetron Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ondansetron Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ondansetron Hydrochloride to their clients by showing that a Ondansetron Hydrochloride CEP has been issued for it. The manufacturer submits a Ondansetron Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ondansetron Hydrochloride CEP holder for the record. Additionally, the data presented in the Ondansetron Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ondansetron Hydrochloride DMF.
A Ondansetron Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ondansetron Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ondansetron Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Ondansetron Hydrochloride written confirmation (Ondansetron Hydrochloride WC) is an official document issued by a regulatory agency to a Ondansetron Hydrochloride manufacturer, verifying that the manufacturing facility of a Ondansetron Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ondansetron Hydrochloride APIs or Ondansetron Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ondansetron Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ondansetron Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ondansetron Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ondansetron Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ondansetron Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ondansetron Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ondansetron Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ondansetron Hydrochloride suppliers with NDC on PharmaCompass.
Ondansetron Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ondansetron Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ondansetron Hydrochloride GMP manufacturer or Ondansetron Hydrochloride GMP API supplier for your needs.
A Ondansetron Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ondansetron Hydrochloride's compliance with Ondansetron Hydrochloride specifications and serves as a tool for batch-level quality control.
Ondansetron Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ondansetron Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ondansetron Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ondansetron Hydrochloride EP), Ondansetron Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ondansetron Hydrochloride USP).